Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?

Chia Hao Chang, Chih Hsin Lee, Jann Yuan Wang

Research output: Contribution to journalLetter

3 Citations (Scopus)

Fingerprint Dive into the research topics of 'Gefitinib or erlotinib for previously treated lung adenocarcinoma: Which is superior?'. Together they form a unique fingerprint.